Can Letrozole Impact Postmenopausal Bones?

Letrozole is a commonly prescribed aromatase inhibitor for the treatment of hormone receptor-positive breast cancer in postmenopausal women. While it has shown great efficacy in inhibiting tumor growth, there have been concerns about its potential impact on postmenopausal bones.

This is because estrogen plays a crucial role in maintaining bone health and letrozole works by suppressing estrogen production in the body. As a result, there have been studies examining the effect of letrozole on bone mineral density (BMD) and fracture risk in postmenopausal women.

In this article, we will explore the current evidence regarding the impact of letrozole on postmenopausal bones and discuss potential strategies for managing bone health in breast cancer patients treated with this medication.

The Role of Estrogen in Maintaining Bone Health

Estrogen is a hormone that plays a vital role in maintaining bone health. It helps regulate bone remodeling, which is the process of breaking down old bone tissue and replacing it with new bone tissue. This process ensures that bones stay strong and healthy.

During menopause, there is a natural decline in estrogen levels as the ovaries stop producing eggs. This decrease in estrogen can lead to bone loss and an increased risk of osteoporosis, a condition where bones become weak and brittle.

Estrogen deficiency can also affect bone density by altering the activity of osteoblasts and osteoclasts, which are responsible for building and breaking down bone tissue respectively. Without enough estrogen, osteoclasts may become more active, leading to greater bone breakdown and a decrease in bone density.

Additionally, estrogen helps increase the absorption of calcium, an essential mineral for maintaining strong bones. Therefore, low estrogen levels can also result in decreased calcium levels and contribute to osteoporosis.

The Impact of Letrozole on Bone Health

Letrozole is an aromatase inhibitor that works by blocking the production of estrogen in the body. As a result, it has been a cause for concern among postmenopausal women being treated with this medication for breast cancer.

Several studies have shown that letrozole can decrease bone mineral density (BMD) in postmenopausal women. One study found that after two years of treatment, there was an average decrease of 3.8% in BMD in the lumbar spine and 2.4% in the femoral neck, which are common sites for osteoporotic fractures.

Another study compared women receiving letrozole with those receiving tamoxifen, another breast cancer medication that does not affect estrogen levels. It found that after two years of treatment, there was a significant decrease in BMD in the letrozole group, while there was no significant change in the tamoxifen group.

Can Letrozole Impact Postmenopausal Bones?

Now , the question arises – can letrozole actually have a clinically significant impact on postmenopausal bones? While there is evidence that it can decrease BMD in some women, it does not necessarily mean that these women will develop osteoporosis or experience an increased risk of fractures. Other factors such as age, body mass index, and lifestyle habits also play a role in maintaining bone health.

Moreover, the benefits of letrozole in treating breast cancer cannot be overlooked. The potential impact on bone health should not outweigh its efficacy in preventing tumor growth and improving survival rates.

Plus, there are strategies that can be implemented to manage bone health in patients receiving letrozole. This includes lifestyle modifications such as regular exercise and a healthy diet rich in calcium and vitamin D, as well as the use of bone-strengthening medications if necessary.

Additionally, close monitoring of BMD levels and prompt treatment for osteoporosis can help prevent fractures and maintain overall bone health in postmenopausal women receiving letrozole.

Tips for Maintaining Bone Health During Treatment

Here are some tips for maintaining bone health during treatment with letrozole:

  • Stay physically active: Weight-bearing exercises such as walking, jogging, and weightlifting can help maintain BMD.
  • Eat a balanced diet: Consume calcium-rich foods such as milk, yogurt, cheese, and leafy greens. Consider taking calcium and vitamin D supplements if necessary.
  • Avoid smoking and excessive alcohol consumption: Both of these habits can contribute to bone loss.
  • Discuss with your doctor: Talk to your doctor about your individual risk factors for osteoporosis and strategies for managing bone health during treatment.
  • Consider bone-strengthening medication: If necessary, your doctor may recommend medications such as bisphosphonates or denosumab to help maintain BMD and prevent fractures.

Pros and Cons of Letrozole Treatment

While letrozole has shown great efficacy in treating breast cancer, it is essential to weigh its potential impact on bone health. Some pros and cons of letrozole treatment include:


  • Highly effective in preventing tumor growth and improving survival rates.
  • Generally well-tolerated with minimal side effects.
  • Can be taken orally, making it convenient for patients.


  • May decrease BMD in postmenopausal women, potentially leading to osteoporosis and an increased risk of fractures.
  • Can cause menopausal symptoms such as hot flashes and mood changes.
  • May interact with other medications, so it is crucial to discuss all current medications with your doctor before starting treatment.


Can letrozole cause osteoporosis?

While letrozole can decrease BMD in postmenopausal women, it does not necessarily mean that it will cause osteoporosis. Other factors and strategies such as lifestyle modifications and regular monitoring can help prevent bone loss.

What should I do if I am experiencing menopausal symptoms while taking letrozole?

Talk to your doctor about managing menopausal symptoms, such as hot flashes and mood changes, while taking letrozole. They may be able to recommend strategies or prescribe medication to help alleviate these symptoms.

How often should my BMD be monitored during treatment with letrozole?

It is recommended to have a baseline BMD before starting treatment and then have it monitored every 1-2 years. However, your doctor may recommend more frequent monitoring depending on your individual risk factors and response to treatment.

Are there any alternative medications for breast cancer that do not affect bone health?

Yes, there are other options such as tamoxifen or aromatase inhibitors like anastrozole that have a lower impact on bone health compared to letrozole. Talk to your doctor about which treatment option is best for you. 


While letrozole can have a negative impact on bone health, it is essential to consider its benefits in treating breast cancer. With proper management and monitoring, the potential effects on BMD can be minimized, and overall bone health can be maintained during treatment.

Discuss with your doctor about strategies for maintaining bone health while receiving letrozole, and continue to prioritize your overall well-being during your cancer treatment journey.  So, it is important to have an open and honest conversation with your doctor about any concerns or questions you may have related to letrozole and its impact on bone health.

Together, you can make informed decisions about your treatment plan that takes into account both the benefits and potential risks. Remember, taking care of your physical and emotional well-being is crucial in fighting cancer, and your medical team is there to support you every step of the way.

Shopping Cart